Everest Organics (EVERESTO) Share Price Falls 9.56% as Stock Hits Rs 226.20
- October 21, 2026
- Posted by: Kunal Singla
- Category: News
Everest Organics Share Price was at Rs 226.20, down 9.56% in the latest session, with market capitalisation at Rs 249.44 Cr. Everest Organics Share Price Today is notable because the stock moved sharply from its previous close of Rs 250.10, even before the market had fully progressed through the session. Univest figures confirm the price action, but they do not point to a specific company trigger. In that context, Everest Organics Share Price News is best read through the actual price action, valuation ratios and sector benchmarks rather than any unverified trigger. The move places Everest Organics Share Price under immediate investor focus within healthcare and pharmaceuticals & drugs, where peer comparisons are important for interpretation. Univest data also shows that the stock has moved within a relatively narrow intraday range, which helps frame the day’s decline without adding speculation.
Everest Organics (EVERESTO) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 226.2 |
| Previous Close | Rs 250.1 |
| Today's Move | -Rs 23.90 (-9.56%) |
| Open | Rs 253 |
| High | Rs 253 |
| Low | Rs 226.2 |
| Market Capitalisation | Rs 249.44 crore |
| Market Cap Category | Micro Cap |
Everest Organics Share Price Today reflects a clear intraday decline. The stock opened at Rs 253.00, touched a high of Rs 253.00 and a low of Rs 226.20, with the last traded level also at Rs 226.20. That means the entire day’s range is visible in the current price, and the move from the previous close of Rs 250.10 to Rs 226.20 equals a fall of Rs 23.90. Everest Organics Share Price therefore shows a session where the opening level was above the prior close, but the price later shifted lower and stayed at the day’s low. Market capitalisation of Rs 249.44 Cr places the company in the Micro Cap category, which is the exact size context used here. For readers tracking Everest Organics Share Price Live or Everest Organics Share Price Update, the key point is that the decline is fully reflected in today’s intraday path, not in any unverified narrative. That sets up the broader Everest Organics Stock Analysis and the next section on fundamentals.
Everest Organics (EVERESTO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 249.44 crore |
| P/E Ratio | 47.47x |
| P/B Ratio | 3.1x |
| ROE | -2.25% |
| ROCE | 1.76% |
| EPS | Rs 5.27 |
| Book Value Per Share | Rs 80.8 |
| Dividend Yield | 0% |
Everest Organics (EVERESTO) fundamental metrics show P/E 47.47x, P/B 3.1x, ROE -2.25%, ROCE 1.76%. Taken on their own, these numbers offer context rather than a trading signal.
Everest Organics has a market capitalisation of Rs 249.44 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 47.47x, P/B at 3.1x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -2.25% and ROCE of 1.76%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.27, book value per share of Rs 80.8, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 47.47x |
| Benchmark Median P/E | 31.73x |
| Benchmark Average P/E | 45.98x |
| Benchmark P/E Range | 3.1x to 616.89x |
| Company P/B Ratio | 3.1x |
| Benchmark Median P/B | 2.76x |
| Benchmark Average P/B | 4.11x |
| Company ROE | -2.25% |
| Benchmark Median ROE | 11.33% |
| Benchmark Average ROE | 10.14% |
| Company ROCE | 1.76% |
| Benchmark Median ROCE | 13.25% |
| Benchmark Average ROCE | 13.05% |
| Company Market Capitalisation | Rs 249.44 crore |
| Benchmark Median Market Cap | Rs 771.43 crore |
| Benchmark Average Market Cap | Rs 13,467.03 crore |
Everest Organics (EVERESTO) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Everest Organics (EVERESTO) has a P/E ratio of 47.47x, which is above the benchmark median of 31.73x, a difference of +49.61%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Everest Organics (EVERESTO) has a ROE of -2.25%, which is below the benchmark median of 11.33%, a difference of -119.86%. Everest Organics (EVERESTO) has a ROCE of 1.76%, which is below the benchmark median of 13.25%, a difference of -86.72%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,18,683.95 | 34.61 | 4.84 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,41,310.94 | 82.5 | 13.66 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,73,078.79 | 79.36 | 19.28 | 26.76 | 19.27 |
| Laurus Labs | LAURUSLABS | 1,11,433.99 | 101.92 | 19.76 | 18.31 | 18.2 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,022.18 | 24.6 | 4.12 | 19.69 | 21.39 |
Everest Organics (EVERESTO) has a P/E ratio of 47.47x compared with the displayed peer median of 79.36x. The comparison is relative and should not be read as a recommendation. Its ROE of -2.25% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 1.76% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Everest Organics (EVERESTO) has a market capitalisation of Rs 249.44 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Everest Organics
- Everest Organics Share Price fell 9.56% to Rs 226.20, making the latest session the main market event to track.
- Everest Organics Share Price Today shows the stock moved from Rs 253.00 to the day’s low at Rs 226.20.
- Everest Organics Share Price sits at a P/E of 47.47 and P/B of 3.1, which keeps valuation in focus.
- Everest Organics Share Price also carries ROE of -2.25% and ROCE of 1.76%, both below the industry benchmark.
- Everest Organics Share Price is being read against the Healthcare sector and Pharmaceuticals & Drugs peer set, where larger names show stronger return metrics.
About Everest Organics
Everest Organics operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For readers following Everest Organics Share Price, that business context matters because pharmaceutical companies are typically assessed through earnings power, return ratios and industry comparison. Everest Organics Share Price also needs to be viewed as a Micro Cap stock, which means market-cap context is important when comparing it with larger listed peers. Univest data places the company within a broader healthcare universe rather than isolating it from the rest of the sector. In practical terms, Everest Organics Share Price News and Everest Organics Stock News should be interpreted with the company’s size, valuation and return profile in mind.
Track Everest Organics Share Price on Univest
Use Everest Organics (EVERESTO) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Everest Organics Share Price on Univest for live price updates, valuation ratios, 52-week levels and market insights in one place. Everest Organics Share Price Today, Everest Organics Share News and Everest Organics Stock Analysis are easier to follow when price action, fundamentals and peer context are kept together. Univest also helps users review the same stock alongside broader healthcare benchmarks.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Everest Organics Share Price fall today?
Ans. Everest Organics Share Price fell 9.56% to Rs 226.20 from Rs 250.10. Univest figures confirm the price action, but they do not point to a specific company trigger. The move is best read through intraday price action.
What is Everest Organics Share Price today?
Ans. Everest Organics Share Price Today is Rs 226.20. The stock was down Rs 23.90, or 9.56%, versus the previous close. The session also showed a high of Rs 253.00 and a low of Rs 226.20.
What is the market cap of Everest Organics?
Ans. Everest Organics has a market capitalisation of Rs 249.44 Cr. That places the company in the Micro Cap category and below the benchmark median market cap seen across the same industry set.
How is Everest Organics Share Price valued?
Ans. Everest Organics Share Price carries a P/E of 47.47 and a P/B of 3.1. The P/E is above the industry median of 31.73, while the P/B is slightly above the benchmark median of 2.76.
What do ROE and ROCE show for Everest Organics?
Ans. Everest Organics reports ROE of -2.25% and ROCE of 1.76%. Both are below the industry benchmark medians, which indicates a weaker return profile than the broader Pharmaceuticals & Drugs set.
What is the EPS and book value for Everest Organics?
Ans. Everest Organics has EPS of Rs 5.27 and book value of Rs 80.8 per share. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
Does Everest Organics offer a dividend yield?
Ans. Everest Organics has a dividend yield of 0. That means the current visible metrics do not show a payout contribution, so Everest Organics Share Price should be assessed mainly on earnings, book value and returns.
How does Everest Organics compare with peers?
Ans. Everest Organics Share Price is much smaller than Sun Pharma, Divi's Laboratories, Torrent Pharmaceuticals, Laurus Labs, Zydus Lifesciences, Cipla, Dr. Reddy's, Mankind Pharma, Aurobindo Pharma and Lupin. Its ROE and ROCE are also weaker than the peer set.
Should investors track Everest Organics Share Price on Univest?
Ans. Yes. Univest lets users track Everest Organics Share Price Today, valuation ratios, sector comparison and market cap in one place. That helps readers connect the day’s price fall with fundamentals and industry context.
